G. Koumakis

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 689 citations · Full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

Advanced Ovarian Cancer, Medicine, Pharmacology +9

Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines

M. Vassilomanolakis, G. Koumakis, V. Barbounis et al. · Annals of Oncology · 2000 · 36 citations · Full text

Breast Oncology, Oncology, Medicine +6

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

Elena Fountzilas, Georgia-Angeliki Koliou, Athanassios Vozikis et al. · ESMO Open · 2020 · 36 citations · Full text

Advanced Breast Cancer, Breast Oncology, Oncology +8

Vinorelbine and Cisplatin for Metastatic Breast Cancer: A Salvage Regimen in Patients Progressing After Docetaxel and Anthracycline Treatment

M. Vassilomanolakis, G. Koumakis, M. Demiri et al. · Cancer Investigation · 2003 · 30 citations